BioCentury
ARTICLE | Company News

Chronogen, McGill University deal

November 25, 2002 8:00 AM UTC

Chronogen exclusively licensed from the university proteins CLK-1, CLK-2, and ISP-1, in addition to a series of targets for age-dependent diseases like cardiovascular disorders and cancer. The compan...